Causal inference in survival analysis using longitudinal observational data: Sequential trials and marginal structural models
Longitudinal observational data on patients can be used to investigate causal effects of time‐varying treatments on time‐to‐event outcomes. Several methods have been developed for estimating such effects by controlling for the time‐dependent confounding that typically occurs. The most commonly used...
Gespeichert in:
Veröffentlicht in: | Statistics in medicine 2023-06, Vol.42 (13), p.2191-2225 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Longitudinal observational data on patients can be used to investigate causal effects of time‐varying treatments on time‐to‐event outcomes. Several methods have been developed for estimating such effects by controlling for the time‐dependent confounding that typically occurs. The most commonly used is marginal structural models (MSM) estimated using inverse probability of treatment weights (IPTW) (MSM‐IPTW). An alternative, the sequential trials approach, is increasingly popular, and involves creating a sequence of “trials” from new time origins and comparing treatment initiators and non‐initiators. Individuals are censored when they deviate from their treatment assignment at the start of each “trial” (initiator or noninitiator), which is accounted for using inverse probability of censoring weights. The analysis uses data combined across trials. We show that the sequential trials approach can estimate the parameters of a particular MSM. The causal estimand that we focus on is the marginal risk difference between the sustained treatment strategies of “always treat” vs “never treat.” We compare how the sequential trials approach and MSM‐IPTW estimate this estimand, and discuss their assumptions and how data are used differently. The performance of the two approaches is compared in a simulation study. The sequential trials approach, which tends to involve less extreme weights than MSM‐IPTW, results in greater efficiency for estimating the marginal risk difference at most follow‐up times, but this can, in certain scenarios, be reversed at later time points and relies on modelling assumptions. We apply the methods to longitudinal observational data from the UK Cystic Fibrosis Registry to estimate the effect of dornase alfa on survival. |
---|---|
ISSN: | 0277-6715 1097-0258 |
DOI: | 10.1002/sim.9718 |